U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07290270) titled 'Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)' on Nov. 17.
Brief Summary: This non-interventional, observational, multicenter, prospective cohort study is designed to investigate the treatment patterns of mPC patients treated with lutetium (177Lu) vipivotide tetraxetan, as well as their clinical outcomes, real-world characteristics, and quality of life during the treatment period and up to one year after treatment completion.
Study Start Date: Dec. 22
Study Type: OBSERVATIONAL
Condition:
Metastatic Prostate Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novartis Pharmaceuticals
Disclai...